Clinical Trials Directory

Trials / Completed

CompletedNCT06430723

The Impact of Obesity on Short Stem Total Hip Arthroplasty

Obesity and it's Impact on Subsidence and Clinical Outcomes After Short Stem Total Hip

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Krankenhaus Barmherzige Schwestern Linz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to review the impact of obesity on subsidence and clinical outcome after short stem total hip arthroplasty.

Detailed description

Short stem total hip arthroplasty (THA) has gained popularity due to its bone-sparing technique, but its outcomes in obese patients remain uncertain. While studies on the mid-term outcome in a general patient cohort provide excellent results in terms of the clinical and radiological outcome as well as the complication rate of short stem THA, data on its use in obese patients is still rare and not sufficiently conclusive. Some studies have found no evidence of increased subsidence in obese patients, while other studies have shown contrary trends. In this context, the aim of this study was to investigate the relationship between BMI, postoperative subsidence and clinical outcomes in the setting of short stem THA.

Conditions

Interventions

TypeNameDescription
PROCEDURETotal hip arthroplastyTotal hip arthroplasty using short stem via an minimally invasive anterolateral approach

Timeline

Start date
2018-01-01
Primary completion
2023-12-31
Completion
2024-01-31
First posted
2024-05-28
Last updated
2024-06-11

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT06430723. Inclusion in this directory is not an endorsement.